Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children

被引:19
|
作者
Ali, Salah [1 ]
Gassas, Adam [1 ]
Kirby-Allen, Melanie [1 ]
Krueger, Joerg [1 ]
Ali, Muhammad [1 ]
Schechter, Tal [1 ]
机构
[1] Univ Toronto, Div Hematol Oncol BMT, Hosp Sick Children, Toronto, ON, Canada
关键词
Eltrombopag; stem cell transplant; thrombocytopenia; thrombopoietin receptor agonist; THROMBOPOIETIN RECEPTOR AGONIST; PROLONGED THROMBOCYTOPENIA; MULTICENTER;
D O I
10.1111/petr.13017
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Secondary failure of platelet engraftment occurs in 20% of patients undergoing allogeneic HSCT and is associated with poor outcome. Currently, there are no guidelines for treatment of late thrombocytopenia and platelet transfusion is the mainstay of treatment. Here, we describe the use of Eltrombopag to treat secondary failure of platelet recovery following HSCT in a child with severe aplastic anemia. Eltrombopag resulted in recovery of platelet count with no need for platelet transfusion support with no reported side effects. Eltrombopag may be used successfully in children with secondary failure of platelet recovery post-HSCT for SAA.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Support group for parents of children post-allogeneic stem cell transplantation
    Hutt, D
    Weiss, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S262 - S263
  • [22] Comment on: Eltrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children
    Akyay, Arzu
    Oncul, Yurday
    PEDIATRIC BLOOD & CANCER, 2020, 67 (09)
  • [23] Venous Thromboembolism Post-allogeneic Hematopoietic Cell Transplant: Risk Factors, Incidence, and Outcomes
    Granat, Lauren M.
    Li, Hong
    Ondeck, Mariah
    Osantowski, Bennet
    Peysin, Chana
    Wilks, Mailey
    Ferraro, Christina
    Sobecks, Ronald
    Angelini, Dana
    Hamilton, Betty K.
    THROMBOSIS AND HAEMOSTASIS, 2025, 125 (02) : 155 - 162
  • [24] Clinical Characteristics and Response Rates to Eltrombopag for Primary and Secondary Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplant (HCT)
    Wang, Trent P.
    Alencar, Maritza C.
    Ramirez, Juan
    Oliva, Maikel Valdes
    Cisneros, Selgrys
    Jean, Pepita
    Baquero, Laura
    Pereira, Denise
    Beitinjaneh, Amer
    Goodman, Mark
    Lekakis, Lazaros J.
    Jimenez, Antonio M.
    Komanduri, Krishna V.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [25] Post-Transplant Platelet Recovery Kinetics and Its Association with Overall Survival in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
    Li, Jie
    Deppa, Jillian Alyse
    Ali, Zahir
    Graiser, Michael
    Langston, Amelia
    Gleason, Charise
    Thomas, Jessica
    Waller, Edmund K.
    BLOOD, 2011, 118 (21) : 899 - 900
  • [26] Real-World Effectiveness and Safety of Hetrombopag for Delayed Platelet Engraftment Post-Allogeneic Hematopoietic Stem Cell Transplantation
    Zhu, Jun
    Lou, Yun
    Zhao, Chuxian
    Jiang, Ying
    Wei, Daolin
    Wang, Chun
    Shao, Shan
    Liu, Huixia
    Li, Su
    BLOOD, 2023, 142
  • [27] ADHERENCE TO THE POST-ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) MEDICAL REGIMEN: A DYADIC CHALLENGE FOR THE PATIENT AND FAMILY CAREGIVER
    Posluszny, Donna M.
    Agha, Mounzer
    Hou, Jing-Zhou
    Mapara, Markus
    Raptis, Anastasios
    Bovbjerg, Dana H.
    Dew, Mary Amanda
    ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 202 - 202
  • [28] Enterococcus as an Infectious Trigger for Hemophagocytic Lymphohistiocytosis (HLH) in AML Patients Post-Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
    Mehyar, Lubna
    Pateva, Irina
    Hashem, Hasan
    Deblank, Peter
    Dalal, Jignesh D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S292 - S293
  • [29] Psychological states and needs among post-allogeneic hematopoietic stem cell transplantation survivors
    Sun, Yanling
    Yan, Pu
    Xu, Duorong
    Zhong, Zhiyong
    Xu, Ting
    Xin, Wenjun
    Zhang, Xiangzhong
    Zhang, Jingwen
    CANCER MEDICINE, 2023, 12 (15): : 16637 - 16648
  • [30] Recurrent Hypoglycemia during Sorafenib Maintenance Post-Allogeneic Hematopoietic Stem Cell Transplantation
    Desai, Nihar
    Viswabandya, Auro
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024,